Nugraha Raka A, Muliawan Hary S, Nugroho Nyityasmono T, Ikhsan Muhammad, Adiarto Suko
Department of General Medicine, Universitas Indonesia Hospital, Depok, Indonesia.
Department of Cardiology and Vascular Medicine, National Cardiovascular Center Harapan Kita/Universitas Indonesia Hospital, Depok, Indonesia.
Int J Angiol. 2021 Oct 1;32(3):197-201. doi: 10.1055/s-0041-1735200. eCollection 2023 Sep.
Since its first discovery in late 2019, coronavirus disease 2019 (COVID-19) has been a global burden associated with significant morbidity and mortality. COVID-19 has been correlated with the development of hypercoagulable state that predisposes the patients to a higher risk of thromboembolism. Current evidence suggests higher incidence of thrombosis, particularly venous thrombosis, among hospitalized COVID-19 patients, mostly with critical illness. On the other hand, there is currently no data regarding the incidence of vivid thrombosis in ambulatory patients with mild COVID-19 and the incidence of concomitant arterial and venous thrombosis in COVID-19 is extremely rare. Herein, we describe catastrophic outcomes of concomitant lower limb arterial and venous thrombosis in a patient with mild COVID-19. This report highlights the occurrence of concomitant arterial and venous thrombosis in ambulatory setting and that this phenomenon resulted in catastrophic clinical consequences.
自2019年末首次发现以来，2019冠状病毒病（COVID-19）一直是一个全球性负担，伴随着显著的发病率和死亡率。COVID-19与高凝状态的发展相关，这使患者更容易发生血栓栓塞。目前的证据表明，住院的COVID-19患者，尤其是危重症患者，血栓形成的发生率更高，尤其是静脉血栓形成。另一方面，目前尚无关于轻症COVID-19门诊患者发生动静脉血栓形成的发生率的数据，且COVID-19患者同时发生动脉和静脉血栓形成的情况极为罕见。在此，我们描述了一名轻症COVID-19患者同时发生下肢动脉和静脉血栓形成的灾难性后果。本报告强调了在门诊环境中同时发生动脉和静脉血栓形成的情况，以及这一现象导致的灾难性临床后果。
